Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haakon B Nygaard

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Biological Psychiatry|July 16, 2017
Targeting Fyn Kinase in Alzheimer's DiseaseHaakon B Nygaard
Clinical Therapeutics|October 22, 2013
Current and emerging therapies for Alzheimer's diseaseHaakon B Nygaard
Archives of Neurology|November 11, 2009
Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer diseaseHaakon B Nygaard, Stephen M Strittmatter
Neurology|August 5, 2009
Lower back pain caused by tophaceous gout of the spineHaakon B Nygaard, Sheela Shenoi, Salil Shukla
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Ketogenic Approaches for the Treatment of Alzheimer's DiseaseRenata Gabuzyan, Christopher Lee, Haakon B Nygaard
Progress in Neurobiology|May 29, 2020
The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease ModelingChristopher Lee, Stephanie M Willerth, Haakon B Nygaard
Dementia (London, England)|May 30, 2020
Community participation in activities and places among older adults with and without dementiaHabib Chaudhury, Tanveer Mahal, Kishore Seetharaman, et al.
Journal of Alzheimer'S Disease : JAD|July 12, 2018
Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576Brianne A Kent, Stephen M Strittmatter, Haakon B Nygaard
Progress in Neurobiology|September 3, 2020
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's diseaseBrianne A Kent, Howard H Feldman, Haakon B Nygaard
Alzheimer'S Research & Therapy|February 6, 2014
Fyn kinase inhibition as a novel therapy for Alzheimer's diseaseHaakon B Nygaard, Christopher H van Dyck, Stephen M Strittmatter
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Biological Psychiatry|July 16, 2017
Targeting Fyn Kinase in Alzheimer's DiseaseHaakon B Nygaard
Clinical Therapeutics|October 22, 2013
Current and emerging therapies for Alzheimer's diseaseHaakon B Nygaard
Archives of Neurology|November 11, 2009
Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer diseaseHaakon B Nygaard, Stephen M Strittmatter
Neurology|August 5, 2009
Lower back pain caused by tophaceous gout of the spineHaakon B Nygaard, Sheela Shenoi, Salil Shukla
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Ketogenic Approaches for the Treatment of Alzheimer's DiseaseRenata Gabuzyan, Christopher Lee, Haakon B Nygaard
Progress in Neurobiology|May 29, 2020
The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease ModelingChristopher Lee, Stephanie M Willerth, Haakon B Nygaard
Dementia (London, England)|May 30, 2020
Community participation in activities and places among older adults with and without dementiaHabib Chaudhury, Tanveer Mahal, Kishore Seetharaman, et al.
Journal of Alzheimer'S Disease : JAD|July 12, 2018
Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576Brianne A Kent, Stephen M Strittmatter, Haakon B Nygaard
Progress in Neurobiology|September 3, 2020
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's diseaseBrianne A Kent, Howard H Feldman, Haakon B Nygaard
Alzheimer'S Research & Therapy|February 6, 2014
Fyn kinase inhibition as a novel therapy for Alzheimer's diseaseHaakon B Nygaard, Christopher H van Dyck, Stephen M Strittmatter
Pageof 6